p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group

JAMA ◽  
1997 ◽  
Vol 277 (19) ◽  
pp. 1531-1538 ◽  
Author(s):  
E. Abraham
Keyword(s):  
Septic Shock ◽  
Severe Sepsis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Receptor ◽  
Multicenter Trial ◽  
Study Group ◽  
Randomized Controlled ◽  
Sepsis And Septic Shock ◽  
Necrosis Factor

Tumor Necrosis Factor gene polymorphism results in high TNF level in sepsis and septic shock

Cytokine ◽  
2013 ◽  
Vol 61 (2) ◽  
pp. 676-681 ◽  
Author(s):  
Nikhil Kothari ◽  
Jaishri Bogra ◽  
Haider Abbas ◽  
Monica Kohli ◽  
Anita Malik ◽  
...  
Keyword(s):  
Septic Shock ◽  
Tumor Necrosis Factor ◽  
Gene Polymorphism ◽  
Tumor Necrosis ◽  
Factor Gene ◽  
Tumor Necrosis Factor Gene ◽  
Sepsis And Septic Shock ◽  
Necrosis Factor

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock

1996 ◽  
Vol 24 (5) ◽  
pp. 733-742 ◽  
Author(s):  
Konrad Reinhart ◽  
Carola Wiegand-Lohnert ◽  
Friedrich Grimminger ◽  
Martin Kaul ◽  
Stuart Withington ◽  
...  
Keyword(s):  
Septic Shock ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Antibody Fragment ◽  
Safety And Efficacy ◽  
Sepsis And Septic Shock ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document